Загрузка...
The reasons to include the serology of human T-lymphotropic virus types 1 and 2 (HTLV-1 and HTLV-2) in the clinical follow-up of patients with viral hepatitis B and C in Brazil
BACKGROUND: The WHO established targets for 2030 to globally reduce new viral hepatitis B and C infections by 90% and deaths by 65% and recommends searching for coinfections that increase the progression of chronic liver infections towards cirrhosis and hepatocellular carcinoma. AIMS AND METHODOLOGY...
Сохранить в:
| Опубликовано в: : | PLoS Negl Trop Dis |
|---|---|
| Главные авторы: | , , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Public Library of Science
2020
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7274452/ https://ncbi.nlm.nih.gov/pubmed/32453768 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pntd.0008245 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|